Impaired Sensorimotor Processing During Complex Gait Precedes Behavioral Changes in Middle-aged Adults

J Gerontol A Biol Sci Med Sci. 2019 Nov 13;74(12):1861-1869. doi: 10.1093/gerona/gly210.

Abstract

Gait impairment during complex walking in older adults is thought to result from a progressive failure to compensate for deteriorating peripheral inputs by central neural processes. It is the primary hypothesis of this article that failure of higher cerebral adaptations may already be present in middle-aged adults who do not present observable gait impairments. We, therefore, compared metabolic brain activity during steering of gait (ie, complex locomotion) and straight walking (ie, simple locomotion) in young and middle-aged individuals. Cerebral distribution of [18F]-fluorodeoxyglucose, a marker of brain synaptic activity, was assessed during over ground straight walking and steering of gait using positron emission tomography in seven young adults (aged 24 ± 3) and seven middle-aged adults (aged 59 ± 3). Brain regions involved in steering of gait (posterior parietal cortex, superior frontal gyrus, and cerebellum) are retained in middle age. However, despite similar walking performance, there are age-related differences in the distribution of [18F]-fluorodeoxyglucose during steering: middle-aged adults have (i) increased activation of precentral and fusiform gyri, (ii) reduced deactivation of multisensory cortices (inferior frontal, postcentral, and fusiform gyri), and (iii) reduced activation of the middle frontal gyrus and cuneus. Our results suggest that preclinical decline in central sensorimotor processing in middle age is observable during complex walking.

Keywords: Behavior; Cerebral glucose metabolism; Complex gait; Middle-age; Positron emission tomography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain Mapping / methods*
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Gait / physiology*
  • Humans
  • Male
  • Middle Aged
  • Neural Pathways / diagnostic imaging*
  • Neural Pathways / metabolism*
  • Positron-Emission Tomography*
  • Radiopharmaceuticals / pharmacokinetics
  • Walking / physiology*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18